Silver Point Capital L.P. Pdl Biopharma, Inc. (PDLI) insider trading activity
Silver Point Capital L.P. is > 10% Shareholder of PDL BIOPHARMA, INC.. Currently has a direct ownership of 24 Million shares of PDLI, which is worth approximately $59.4 Million. The most recent transaction as insider was on Feb 01, 2021, when has been sold 187,061 shares (Common Stock) at a price of $2.05 per share, resulting in proceeds of $383,475. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
24M
0%
3M change
0%
12M change
Total Value Held
$59.4 Million
Silver Point Capital L.P. Transaction History
Also insider at
SPC
Silver Point Capital L.P.
> 10% Shareholder
Greenwich, CT